IndraLab

Statements


CYLD inhibits NTRK1. 1 / 1
| 1

reach
"At a genomic level, we established that neither TRKB and TRKC amplification, nor that of BDNF and NT3/4 was demonstrated to account for the overexpression seen in cylindroma tumours, suggesting that CYLD dysfunction perturbs normal TRK homeostasis."